Skip to main content

Table 1 Inclusion and exclusion criteria

From: A double-blind randomised controlled investigation into the efficacy of Mirococept (APT070) for preventing ischaemia reperfusion injury in the kidney allograft (EMPIRIKAL): study protocol for a randomised controlled trial

Inclusion criteria

1. Patient must be 16 years of age or older and registered on the kidney transplant list.

2. Patient must be willing to participate in the study and provide written informed consent.

3. Patient must have the ability to comply with the study requirements.

4. Donor must be older than 10 years of age.

5. Patient is on dialysis.

Exclusion criteria

1. Patient is recipient of a living-donor kidney.

2. Patient is a recipient of a DCD kidney Maastricht category 1 or 2.

3. Patient has evidence of current infection with HIV, HBV or HCV.

4. Patient is recipient of a paediatric en bloc or a adult double renal transplant.

5. Any recipient of a multi-organ transplant or a previous recipient of a non-renal solid organ transplant.

6. Females who are pregnant or lactating.

7. Male and female patients not willing to use contraception for at least one month post-transplant.

8. Any planned ABO blood group or HLA antibody-incompatible transplant.

9. Patient is involved in other experimental drug trials.